Patents by Inventor Juan R. CUBILLOS-RUIZ

Juan R. CUBILLOS-RUIZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for inducing anti-tumor immunity and methods thereof
    Patent number: 10450566
    Abstract: Described herein is a previously unknown function of XBP1 in controlling anti-tumor immunity. It is shown that inhibiting XBP1 in tumor-associated dendritic cells inhibits tumor growth and induces protective anti-tumor immune responses.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: October 22, 2019
    Assignee: Cornell University
    Inventors: Juan R. Cubillos-Ruiz, Laurie H. Glimcher
  • Compounds for inducing anti-tumor immunity and methods thereof
    Patent number: 10421965
    Abstract: Described herein is a previously unknown function of XBP1 in controlling anti-tumor immunity. It is shown that inhibiting XBP1 in tumor-associated dendritic cells inhibits tumor growth and induces protective anti-tumor immune responses.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: September 24, 2019
    Assignee: Cornell University
    Inventors: Juan R. Cubillos-Ruiz, Laurie H. Glimcher
  • COMPOUNDS FOR INDUCING ANTI-TUMOR IMMUNITY AND METHODS THEREOF
    Publication number: 20180258426
    Abstract: Described herein is a previously unknown function of XBP1 in controlling anti-tumor immunity. It is shown that inhibiting XBP1 in tumor-associated dendritic cells inhibits tumor growth and induces protective anti-tumor immune responses.
    Type: Application
    Filed: January 23, 2018
    Publication date: September 13, 2018
    Inventors: Juan R. Cubillos-Ruiz, Laurie H. Glimcher
  • Compounds for inducing anti-tumor immunity and methods thereof
    Patent number: 9957506
    Abstract: Described herein is a previously unknown function of XBP1 in controlling anti-tumor immunity. It is shown that inhibiting XBP1 in tumor-associated dendritic cells inhibits tumor growth and induces protective anti-tumor immune responses.
    Type: Grant
    Filed: September 25, 2014
    Date of Patent: May 1, 2018
    Assignee: Cornell University
    Inventors: Juan R. Cubillos-Ruiz, Laurie H. Glimcher
  • COMPOUNDS FOR INDUCING ANTI-TUMOR IMMUNITY AND METHODS THEREOF
    Publication number: 20160237429
    Abstract: Described herein is a previously unknown function of XBP1 in controlling anti-tumor immunity. It is shown that inhibiting XBP1 in tumor-associated dendritic cells inhibits tumor growth and induces protective anti-tumor immune responses.
    Type: Application
    Filed: September 25, 2014
    Publication date: August 18, 2016
    Applicant: CORNELL UNIVERSITY
    Inventors: Juan R. CUBILLOS-RUIZ, Laurie H. GLIMCHER